Estimating Inhaled Corticosteroid Exposure from Short-Acting β2-Agonist-Inhaled Corticosteroid Rescue

Njira Lugogo; Ileen Gilbert; Michael Pollack; Hitesh Gandhi; Joseph Tkacz; Miguel J Lanz

doi:10.2147/JAA.S408504

Estimating Inhaled Corticosteroid Exposure from Short-Acting β₂-Agonist-Inhaled Corticosteroid Rescue

J Asthma Allergy. 2023 May 31:16:579-584. doi: 10.2147/JAA.S408504. eCollection 2023.

Authors

Njira Lugogo¹, Ileen Gilbert², Michael Pollack², Hitesh Gandhi², Joseph Tkacz³, Miguel J Lanz⁴

Affiliations

¹ Department of Medicine, Division of Pulmonary and Critical Care Medicine, University of Michigan, Ann Arbor, MI, USA.
² BioPharmaceuticals Medical, AstraZeneca, Wilmington, DE, USA.
³ Inovalon, Bowie, MD, USA.
⁴ Allergy and Asthma, AAADRS Clinical Research Center, Coral Gables, FL, USA.

No abstract available

Grants and funding

AstraZeneca funded the study and had a role in study design, data collection, data analysis, data interpretation, and writing of the report. The corresponding author had full access to all the data and had final responsibility to submit for publication.